Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

MUN/473A stock hub

MUN/473A has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MUN/473Ais not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

337.8K

Munich Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

MUN/473A

In the news

Latest news · MUN/473A

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-1,341.1

P25 n/aP50 n/aP75 n/a

ROIC-152.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MUN/473A market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

138

Groups with data

Currency

USD

Showing 138 of 138 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	DE
Employees	506
Employees Change	57%
Employees Change Percent	12.69
Enterprise value	EUR 19.6M
Exchange	Munich Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 337,781
Price	EUR 0.01
Price currency	EUR
Rev Per Employee	109,525.45x
Sic	2836
Symbol	mun/473A
Website	https://www.adaptimmune.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-42,793.13%
EV Earnings	-0.14x
EV/FCF	-0.12x
EV/Sales	0.35x
FCF yield	-48,316.59%
P/B ratio	-0.01x
P/S ratio	0.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-227.19%
EBITDA Margin	-210.86%
Gross margin	-97.73%
Gross Profit	EUR -54.2M
Net Income	EUR -144.5M
Pretax Margin	-255.12%
Profit Margin	-260.82%
Profit Per Employee	EUR -285,666
ROA	-40.86
Roa5y	-22.63
ROCE	-186.9
ROE	-1,341.1
Roe5y	-138.4
ROIC	-152.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	-53.99x
Revenue Growth Q	-89.33x
Revenue Growth3 Y	77.02x
Revenue Growth5 Y	96.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.29
Assets	EUR 111.2M
Cash	EUR 22.2M
Current Assets	EUR 66.2M
Current Liabilities	EUR 43.7M
Debt	EUR 41.5M
Debt FCF	EUR -0.25
Equity	EUR -60.4M
Interest Coverage	-26.1
Liabilities	EUR 171.7M
Long Term Assets	EUR 45M
Long Term Liabilities	EUR 128M
Net Cash	EUR -19.3M
Net Cash By Market Cap	EUR -5,702
Tangible Book Value	EUR -63.7M
Tangible Book Value Per Share	EUR -0.24

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.52
Inventory Turnover	20.28
Net Working Capital	EUR 4.3M
Quick ratio	1.07
Working Capital	EUR 22.7M
Working Capital Turnover	EUR 0.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.53%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	0.02
All Time High	0.03
All Time High Change	-63.24%
All Time High Date	2026-01-02
All Time Low	0.01
All Time Low Change	0%
All Time Low Date	2026-03-16
ATR	0
High	0.01
High52	0.03
High52 Date	2026-01-12
High52ch	-63.24%
Low	0.01
Low52	0.01
Low52 Date	2026-05-08
Low52ch	0%
Ma50ch	-21.38%
RSI	15.89
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	-2.38x
Sortino ratio	-2.74
Total Return	-8.53%
Tr1m	-24.24%
Tr3m	-40.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -125.9M
Operating margin	-227.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	263,338,113%
Net Borrowing	-382,430.9
Shares Insiders	0.65%
Shares Institutions	0.63%
Shares Qo Q	2.75%
Shares Yo Y	8.53%
Short Ratio	3.57

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -169.9M
Average Volume	2,191.55x
Bv Per Share	-0.23
CAPEX	EUR -1.4M
Ch1m	-24.24
Ch3m	-40.48
Change	0%
Change From Open	0
Close	0.01
Days Gap	0
Depreciation Amortization	9,012,140.1
Earnings Date	2026-05-12
EBIT	EUR -125.9M
EBITDA	EUR -116.9M
EPS	EUR -0.56
F Score	0
FCF	EUR -163.2M
FCF EV Yield	-834.6x
Financing CF	1,137,604
Fiscal Year End	December
Founded	2,008
Income Tax	EUR 3.2M
Investing CF	1,526,740
Is Primary Listing	0
Last Report Date	2025-06-30
Ma20	0.01
Ma20ch	-1.57%
Net CF	-159,143,647
Next Earnings Date	2026-05-12
Open	0.01
Ppne	39,769,417.8
Price Date	2026-05-08
Relative Volume	3.1x
Revenue	55,419,878x
SBC By Revenue	12.11x
Share Based Comp	6,710,672
Tax By Revenue	5.7x
Z Score	-15.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MUN/473A pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns MUN/473A?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.6%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MUN/473A momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

15.9

Below 30: short-term oversold

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-2.38

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MUN/473A

Hub-level FAQ points readers to the deeper analysis pages.

What is the current mun/473A stock rating?

mun/473A is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full mun/473A analysis?

The full report lives at /stocks/mun/473A/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for mun/473A?

The latest report frames mun/473A around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the mun/473A page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.